Total Funding
35
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
99928
Avitide develops affinity purification solutions for biopharmaceutical companies.
Acquired by 
Repligen
- Scott Kennedy: VP and Chief Financial OfficerPast Role: PerkinElmer, VP and CFO, Life Sciences and Technologies
Warren Kett: Co-FounderPast Role: Dartmouth College, Research Scientist
About the Company
Avitide develops customized biopharmaceutical affinity purification products with an industry-leading discovery and development service timeline. The Avitide platform reduces process development timelines, program risks, and cost of production by providing high-resolution custom affinity purification solutions.
The company was founded in 2012 and
is based in Lebanon, New Hampshire.
